The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Incidence of cerebral microbleeds in preclinical Alzheimer disease
Open accessAbstract
OBJECTIVE: We sought to determine the incidence and associations of lobar microbleeds (LMBs) in a longitudinal cohort with (11)C-Pittsburgh compound B (PiB) PET imaging. METHODS: One hundred seventy-four participants from the observational Australian Imaging, Biomarkers and Lifestyle Study of Ageing (97 with normal cognition [NC], 37 with mild cognitive impairment [MCI], and 40 with Alzheimer disease [AD] dementia) were assessed at 3 time points over 3 years with 3-tesla susceptibility-weighted MRI and (11)C-PiB PET. MRIs were inspected for microbleeds, siderosis, infarction, and white matter hyperintensity severity, blind to clinical and PiB findings. Neocortical PiB standardized uptake value ratio, normalized to cerebellar cortex, was dichotomized as positive or negative (PiB+/-, standardized uptake value ratio >1.5). Annualized LMB incidence was calculated, and logistic regression was used to determine the association of incident LMBs with PiB, APOE ε4+ status, and cerebrovascular disease. RESULTS: LMBs were present in 18.6% of NC, 24.3% of MCI, and 40% of AD participants (p < 0.05 vs NC). LMB incidence was 0.2 ± 0.6 per year in NC participants, 0.2 ± 0.5 in MCI, and 0.7 ± 1.4 in AD (p < 0.03 vs NC) and was 6-fold higher in PiB+ than PiB-NC. Incident LMBs were associated with age, APOE ε4+, PiB+, and baseline LMBs. Incidence of multiple LMBs was also associated with lacunar infarction and white matter hyperintensity severity. CONCLUSIONS: Older age, baseline LMBs, higher β-amyloid burden, and concomitant cerebrovascular disease may all confer higher risk of incident LMBs. This should be considered when designing protocols for amyloid-modifying clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This broad range of detection could likely be attributed to the magnet field strength, with clinical strength 1.5 and 3T magnets likely underestimating the incidence of microbleeds compared with the research-grade 7T magnet (83, 246, 452, 530, 604, 669).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [669]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the risk of brain microhemorrhages related to Aβ immunotherapy may be a transient complication and possibly reduced in individuals with modest VAβ burden, who also have lower prevalence of spontaneous microbleeds [58, 59].”
From APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice (2017) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CNS microbleeds reflect loss of cerebrovascular integrity and are found in 25% of individuals with MCI (669) and 45-78% of individuals with early AD without dementia (83, 208, 246, 452, 476, 529, 604, 702).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [669]
The cited source says what the claim attributes to it.
In the citing paper
“Both VAβ and hypertensive or atherosclerotic microangiopathy are recognized clinical risk factors for cerebral microbleeds, with the former correlating stronger with bleeding in cortical/subcortical distribution [58, 59] while the later with bleeding to deep brain structures including basal ganglia and thalamic nuclei [60, 61].”
From APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice (2017) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationMR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging
Fazekas, F., Chawluk, J. B., Alavi, A. A., Hurtig, H. I., & Zimmerman, R. A. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.149.2.351 · Cited by 5,327
Cerebral microbleeds: a guide to detection and interpretation
Greenberg, S. M., Vernooij, M. W., Cordonnier, C., Viswanathan, A., Al-Shahi Salman, R., Warach, S., Launer, L. J., Van Buchem, M. A., & Breteler, M. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70013-4 · Cited by 1,798
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
Knudsen, K. A., Rosand, J., Karluk, D., & Greenberg, S. M. (2001) · Neurology · doi:10.1212/wnl.56.4.537 · Cited by 1,015
Ellis, K. A., Bush, A. I., Darby, D., Fazio, D. D., Foster, J. K., Hudson, P. J., Lautenschlager, N. T., Lenzo, N. P., Martins, R. N., Maruff, P. T., et al. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209009405 · Cited by 1,005
Self-citationAmyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986
Self-citationPrevalence of superficial siderosis in patients with cerebral amyloid angiopathy
Linn, J., Halpin, A., Demaerel, P., Ruhland, J., Giese, A. D., Dichgans, M., van Buchem, M. A., Bruckmann, H., & Greenberg, S. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dad605 · Cited by 914
Sperling, R. A., Jack, C. R., Black, S. E., Frosch, M. P., Greenberg, S. M., Hyman, B. T., Scheltens, P., Carrillo, M. C., Thies, W., Bednar, M. M., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2351 · Cited by 857
The Microbleed Anatomical Rating Scale (MARS)
Gregoire, S. M., Chaudhary, U. J., Brown, M. M., Yousry, T. A., Kallis, C., Jäger, H. R., & Werring, D. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c34a7d · Cited by 855
Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study
Vernooij, M. W., van der Lugt, A., Ikram, M. A., Wielopolski, P. A., Niessen, W. J., Hofman, A., Krestin, G. P., & Breteler, M. M. B. (2008) · Neurology · doi:10.1212/01.wnl.0000307750.41970.d9 · Cited by 793
Longstreth, W. T. (1998) · Archives of Neurology · doi:10.1001/archneur.55.9.1217 · Cited by 573
Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study
Poels, M. M. F., Vernooij, M. W., Ikram, M. A., Hofman, A., Krestin, G. P., van der Lugt, A., & Breteler, M. M. B. (2010) · Stroke · doi:10.1161/strokeaha.110.595181 · Cited by 563
Sperling, R., Salloway, S., Brooks, D. J., Tampieri, D., Barakos, J., Fox, N. C., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70015-7 · Cited by 512
Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage
Greenberg, S. M., Eng, J. A., Ning, M., Smith, E. E., & Rosand, J. M. (2004) · Stroke · doi:10.1161/01.str.0000126807.69758.0e · Cited by 507
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
Johnson, K. A., Gregas, M., Becker, J. A., Kinnecom, C., Salat, D. H., Moran, E. K., Smith, E. E., Rosand, J., Rentz, D. M., Klunk, W. E., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21164 · Cited by 495
Improving Interrater Agreement About Brain Microbleeds
Cordonnier, C., Potter, G. M., Jackson, C., Doubal, F., Keir, S. L., Sudlow, C. L. M., Wardlaw, J. M., & Salman, R. A. (2008) · Stroke · doi:10.1161/strokeaha.108.526996 · Cited by 386
Hawkes, C. A., Härtig, W., Kacza, J., Schliebs, R., Weller, R. O., Nicoll, J. A. R., & Carare, R. O. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0801-7 · Cited by 365
Incidence of Cerebral Microbleeds in the General Population
Poels, M. M. F., Ikram, M. A., van der Lugt, A., Albert Hofman, D., Krestin, G. P., Breteler, M. M. B., & Vernooij, M. W. (2011) · Stroke · doi:10.1161/strokeaha.110.607184 · Cited by 304
Price, T. R., Manolio, T. A., Kronmal, R. A., Kittner, S. J., Yue, N. C., Robbins, J. A., Anton‐Culver, H., & O’Leary, D. H. (1997) · Stroke · doi:10.1161/01.str.28.6.1158 · Cited by 303
Roher, A. E., Kuo, Y., Esh, C. L., Knebel, C., Weiss, N., Kalback, W. M., Luehrs, D. C., Childress, J., Beach, T. G., Weller, R. O., et al. (2003) · Molecular Medicine · doi:10.1007/bf03402043 · Cited by 278
Cerebral microbleeds: histopathological correlation of neuroimaging
Shoamanesh, A., Kwok, C. S., & Benavente, O. (2011) · Cerebrovascular Diseases · doi:10.1159/000331466 · Cited by 258
Itoh, Y., Yamada, M., Hayakawa, M., Otomo, E., & Miyatake, T. (1993) · Journal of Neurological Sciences · doi:10.1016/0022-510x(93)90317-r · Cited by 253
Bokura, H., Kobayashi, S., & Yamaguchi, S. (1998) · Journal of Neurology · doi:10.1007/s004150050189 · Cited by 245
Stiff‐man syndrome treated with intrathecal baclofen
Penn, R. D., & Mangieri, E. A. (1993) · Neurology · doi:10.1212/wnl.43.11.2412 · Cited by 235
Kumar, N., Cohen-Gadol, A. A., Wright, R. A., Miller, G. M., Piepgras, D. G., & Ahlskog, J. E. (2006) · Neurology · doi:10.1212/01.wnl.0000208510.76323.5b · Cited by 232
Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy
Chen, Y. W., Gurol, M. E., Rosand, J. M., Viswanathan, A., Rakich, S. M., Groover, T. R., Greenberg, S. M., & Smith, E. E. (2006) · Neurology · doi:10.1212/01.wnl.0000223613.57229.24 · Cited by 167
Hawkes, C. A., Gatherer, M., Sharp, M. M., Dorr, A. E., Yuen, H. M., Kalaria, R. N., Weller, R. O., & Carare, R. O. (2013) · Aging Cell · doi:10.1111/acel.12045 · Cited by 157
Ayaz, M., Boikov, A. S., Haacke, E. M., Kido, D. K., & Kirsch, W. M. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22001 · Cited by 148
Incidence of cerebral microbleeds
Goos, J. D. C., Henneman, W. J. P., Sluimer, J. D., Vrenken, H., Sluimer, I. C., Barkhof, F., Blankenstein, M. A., Scheltens, P., & van der Flier, W. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e396ea · Cited by 136
Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging.
Haacke, E. M., DelProposto, Z., Chaturvedi, S., Sehgal, V., Tenzer, M., Neelavalli, J., & Kido, D. K. (2007) · PubMed Central · Cited by 135
Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease
Yates, P. A., Sirisriro, R., Villemagne, V. L., Farquharson, S., Masters, C. L., Rowe, C. C., & For the AIBL Research Group (2011) · Neurology · doi:10.1212/wnl.0b013e318221ad36 · Cited by 130
Self-citationPredicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy
Gurol, M. E., Dierksen, G. A., Betensky, R. A., Gidicsin, C. M., Halpin, A., Becker, J. A., Carmasin, J. S., Ayres, A. M., Schwab, K. M., Viswanathan, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826043a9 · Cited by 122
What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?
Cordonnier, C., Leys, D., Dumont, F., Deramecourt, V., Bordet, R., Pasquier, F., & Hénon, H. (2010) · Brain · doi:10.1093/brain/awq246 · Cited by 81
Genetic associations with brain microbleeds
Maxwell, S. S., Jackson, C., Paternoster, L., Cordonnier, C., Thijs, V., Salman, R. A., & Sudlow, C. L. M. (2011) · Neurology · doi:10.1212/wnl.0b013e318224afa3 · Cited by 74
Focal hemosiderin deposits and β‐amyloid load in the ADNI cohort
Kantarci, K., Gunter, J. L., Tosakulwong, N., Weigand, S. D., Senjem, M. L., Petersen, R. C., Aisen, P. S. S., Jagust, W. J., Weiner, M. W., Jack, C. R., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.10.011 · Cited by 71
Dynamic Temporal Change of Cerebral Microbleeds: Long-Term Follow-Up MRI Study
Lee, S., Lee, S., Kim, B. J., Park, H.-K., Kim, C.-K., Jung, K., & Roh, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025930 · Cited by 64
APOE ε2/ε4 polymorphism and cerebral microbleeds on gradient-echo MRI
Kim, M., Bae, H. J., Lee, J., Kang, L., Lee, S., Kim, S., Lee, J. E., Lee, K. M., Yoon, B. W., Kwon, O., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000183311.48144.7f · Cited by 39
O1–03–02: Focal hemosiderin deposits and beta‐amyloid load in the ADNI cohort
Kantarci, K., Gunter, J., Tosakulwong, N., Weigand, S., Senjem, M., Petersen, R., Aisen, P., Jagust, W., Weiner, M., & Jack, C. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.04.062
Cited by
Sorted by citations
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Establishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670
White matter hyperintensities, cognitive impairment and dementia: an update
Prins, N. D., & Scheltens, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.10 · Cited by 1,284
The role of brain vasculature in neurodegenerative disorders
Sweeney, M. D., Kisler, K., Montagne, A., Toga, A. W., & Zlokovic, B. V. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0234-x · Cited by 998
Metadata
- Authors
- Yates, P. A., Desmond, P. M., Phal, P. M., Steward, C., Szoeke, C., Salvado, O., Ellis, K. A., Martins, R. N., Masters, C. L., Ames, D., Villemagne, V. L., Rowe, C. C., & For the AIBL Research Group
- Affiliations
- Edith Cowan University (AU)
- ORCID
- Venue
- Neurology
- Published
- 2014-04-08
- Volume
- 82
- Issue
- 14
- Pages
- 1266-1273
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC4001205
- OpenAlex
- W1992608632
- Cited by
- 150
- References
- 41
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 9 · 2023: 7 · 2022: 16 · 2021: 16 · 2020: 11 · 2019: 13 · 2018: 10 · 2017: 12 · 2016: 13 · 2015: 20 · 2014: 7
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- Research Online (Edith Cowan University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Eli Lilly and Company
- Pfizer
- Commonwealth Scientific and Industrial Research Organisation
- Dementia Collaborative Research Centres, Australia
- H. Lundbeck A/S
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- cerebral microbleeds, lobar microbleeds, preclinical Alzheimer's disease, mild cognitive impairment, amyloid PET, APOE ε4, cerebrovascular disease, lacunar infarction, white matter hyperintensities
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Amyloid, Aniline Compounds, Australia, Brain, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Thiazoles, Incidence, Intracranial Hemorrhages, Positron-Emission Tomography, Cerebral Small Vessel Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
